Table 1.
The demographic and clinical characteristics of patients with DOR and CON.
| Item | DOR group (n=26) | CON group (n=28) | P value |
|---|---|---|---|
| Age (year) | 34.04 ± 3.8 | 30.29 ± 2.62 | < 0.001 *** |
| BMI (kg/m2) | 21.57 ± 1.43 | 20.48 ± 1.74 | 0.016 * |
| bFSH (mIU/ml) | 11.11 ± 4.71 | 6.60 ± 1.75 | < 0.001 *** |
| bLH (mIU/ml) | 4.22 ± 4.36 | 3.65 ± 1.71 | 0.52 |
| bE2 (pg/ml) | 47.55 ± 30.86 | 36.02 ± 17.33 | 0.094 |
| P (ng/ml) | 1.49 ± 2.77 | 0.78 ± 1.03 | 0.21 |
| bAFC (n) | 3.5 ± 1.61 | 10.18 ± 3.35 | < 0.001 *** |
| AMH (ng/mL) | 0.72 ± 0.36 | 4.70 ± 2.49 | < 0.001 *** |
| FBG (mmol/L) | 4.78 ± 0.45 | 5.02 ± 0.31 | 0.474 |
| Duration of infertility (year) | 3.28 ± 2.77 | 2.78 ± 2.31 | 0.021 * |
| Oocytes retrieved (n) | 4.31 ± 2.49 | 15.07 ± 6.43 | < 0.001 *** |
| MII oocytes (n) | 3.12 ± 1.77 | 10.21 ± 4.83 | < 0.001 *** |
| 2PN Fertilizations (n) | 2.38 ± 1.68 | 7.14 ± 4.09 | < 0.001 *** |
| Day3 High-quality embryos (n) | 1.04 ± 1.08 | 4.43 ± 3.56 | < 0.001 *** |
DOR, Diminished ovarian reserve; NOR, Normal ovarian reserve; BMI, Body mass index; bFSH, basic follicle-stimulating hormone; bLH, basic luteinizing hormone; bE2, basic estrogen; P, progesterone; bAFC, basic antral follicle count; AMH, anti-Mullerian hormone; FBG, fasting blood glucose *P ≤ 0.05 **P ≤ 0.005 ***P ≤ 0.001.